Managing intellectual property to develop medicines for the world's poorest

It has been argued that patents impede the development and access of medicines for tropical diseases such as malaria. However, we believe that intellectual property can be a key tool to enable timely progression of drug development projects involving multiple partners and to ensure equitable access...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature reviews. Drug discovery 2017-04, Vol.16 (4), p.223-224
Hauptverfasser:	Fonteilles-Drabek, Sylvie, Reddy, David, Wells, Timothy N. C.
Format:	Artikel
Sprache:	eng
Schlagworte:	631/154/2426/1984 692/699/255/1629 Biomedical and Life Sciences Biomedicine Biotechnology Cancer Research comment Drug discovery Drug Discovery - economics Drug Discovery - organization & administration Drug therapy Forecasts and trends Humans Intellectual Property Malaria - drug therapy Medicinal Chemistry Molecular Medicine Pharmaceutical industry Pharmacology/Toxicology Public-Private Sector Partnerships - economics Public-Private Sector Partnerships - organization & administration Tropical diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	It has been argued that patents impede the development and access of medicines for tropical diseases such as malaria. However, we believe that intellectual property can be a key tool to enable timely progression of drug development projects involving multiple partners and to ensure equitable access to successful products. It has been argued that patents impede the development and access of medicines for tropical diseases such as malaria. However, we believe that intellectual property can be a key tool to enable timely progression of drug development projects involving multiple partners and to ensure equitable access to successful products.
ISSN:	1474-1776 1474-1784
DOI:	10.1038/nrd.2017.24